Concanavalin A (con A) is a potent inhibitor of coagulant activity of native tissue factor. Coagulant activity is recovered by addition of alpha-methyl-D-glucoside to inhibited tissue factor. Inclusion of alpha-methyl-D-glucose during incubation of con A with tissue factor preserves coagulant activity. These data suggest that con A interacts reversibly with a carbohydrate residue in such a way as to inhibit coagulant activity of the molecule. Purified tissue factor apoprotein has been recombined with mixed brain phospholipids or purified phospholipids (phosphatidyl ethanolamine or a mixture of phosphatidyl choline with phosphatidyl serine). These preparations were also completely but reversibly inhibited by con A. Thus, purified tissue factor apoprotein appears to donate the affected carbohydrate residue.
F A Pitlick
Title and authors | Publication | Year |
---|---|---|
Concanavalin-A-assisted extraction-free one-pot RPA-CRISPR/Cas12a assay for rapid detection of HPV16.
Nie Y, Li X, Yang W, Fei S, Wang Y, Li Y, Zhang K, Kang J, Cheng Y, Wang H, Liu D |
Mikrochimica acta | 2025 |
Tissue factor purified from different cellular sources and non-glycosylated tissue factor show similar procoagulant activity
H Kothari, UR Pendurthi, LV Rao |
Journal of Thrombosis and Haemostasis | 2013 |
Comparison of natural and recombinant tissue factor proteins: new insights
S Butenas |
Biological Chemistry | 2013 |
Regulation of tissue factor coagulant activity on cell surfaces
LV Rao, UR Pendurthi |
Journal of Thrombosis and Haemostasis | 2012 |
Tissue factor structure and function
S Butenas |
Scientifica | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Posttranslational modifications of tissue factor
S Butenas, J Amblo-Krudysz, KG Mann |
Frontiers in bioscience (Elite edition) | 2012 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
Glycosylation of tissue factor is not essential for its transport or functions: TF glycosylation
H Kothari, LV Rao, UR Pendurthi |
Journal of Thrombosis and Haemostasis | 2011 |
Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome
SC Sebag, JA Bastarache, LB Ware |
Current pharmaceutical biotechnology | 2011 |
Posttranslational modifications and activity of natural and recombinant tissue factor
S Butenas, J Krudysz-Amblo, KG Mann |
Thrombosis Research | 2010 |
Carbohydrates and Activity of Natural and Recombinant Tissue Factor
J Krudysz-Amblo, ME Jennings, KG Mann, S Butenas |
The Journal of biological chemistry | 2009 |
Tissue Factor in Coagulation: Which? Where? When?
S Butenas, T Orfeo, KG Mann |
Arteriosclerosis, thrombosis, and vascular biology | 2009 |
Regulation of tissue factor procoagulant activity by post-translational modifications
EM Egorina, MA Sovershaev, B Østerud |
Thrombosis Research | 2008 |
Tissue factor upregulation drives a thrombosis–inflammation circuit in relation to cardiovascular complications
AJ Chu |
Cell Biochemistry and Function | 2006 |
Novel Anticoagulant Activity of Polyamino Acid Offsets Bacterial Endotoxin-Induced Extrinsic Hypercoagulation: Downregulation of Monocytic Tissue Factor-Dependent FVII Activation:
AJ Chu, M Rauci, OI Nwobi, ST Mathews, S Beydoun |
Journal of Cardiovascular Pharmacology | 2003 |
Possible role of Marcks in the cellular modulation of monocytic tissue factor-initiated hypercoagulation
AJ Chu, SH Lin, E Piasentin |
British Journal of Haematology | 2002 |
Novel anticoagulant activity of polybrene: inhibition of monocytic tissue factor hypercoagulation following bacterial endotoxin induction
AJ Chu, M Rauci, OI Nwobi, ST Mathews, S Beydoun |
Blood Coagulation & Fibrinolysis | 2002 |
Blockade by ruthenium red of tissue factor-initiated coagulation
AJ Chu, ZG Wang, OI Nwobi, S Beydoun |
British Journal of Pharmacology | 2001 |
Protamine inhibits tissue factor-initiated extrinsic coagulation
AJ Chu, ZG Wang, M Raicu, S Beydoun, N Ramos |
British Journal of Haematology | 2001 |
Antimicrobial Peptide Buforin I Inhibits Tissue Factor-Initiated Coagulation
AJ Chu, BM Chen, H Lin, S Beydoun |
Archives of Biochemistry and Biophysics | 2001 |
Historical review
EB MD |
British Journal of Haematology | 2000 |
IV. Anticoagulant Activity of Compound 48/80: Inhibition of Factor VII Activation in Leukemia THP-1 Monocytes
AJ Chu, ZG Wang, UO Raphael |
Journal of Cardiovascular Pharmacology | 2000 |
III. Instantaneous Inhibition by Compound 48/80 of Tissue Factor-Initiated Extrinsic Coagulation Is Mediated by the Downregulation of Factor VII Activation
AJ Chu, ZG Wang, MJ Fox |
Archives of Biochemistry and Biophysics | 2000 |
I. Suppression by compound 48/80 of bacterial endotoxin-inducible monocytic tissue factor activity: direct blockade of factor VII binding to THP-1 monocytes
A Chu |
Biochimica et Biophysica Acta (BBA) - General Subjects | 1999 |
Compound 48/80 Suppresses Monocytic Tissue Factor-Initiated Extrinsic Blood Coagulation Induced by Bacterial Endotoxin
AJ Chu, UO Raphael, JK Prasad, S Beydoun, N Ramos |
Journal of Surgical Research | 1999 |
I. Suppression by compound 48/80 of bacterial endotoxin-inducible monocytic tissue factor activity: direct blockade of factor VII binding to THP-1 monocytes1This study was presented in part in abstract form to the American Society for Biochemistry and Molecular Biology annual meeting held in San Francisco, CA, 16–20 May 1999.1
AJ Chu, MA Walton, A Seto, MJ Fox, JK Prasad, ZG Wang |
Biochimica et Biophysica Acta (BBA) - General Subjects | 1999 |
Hämostaseologie
G Müller-Berghaus, B Pötzsch |
Hämostaseologie | 1999 |
Antagonism by ethanol of endotoxin-induced tissue factor activation in relation to the depressed endotoxin binding to monocyte-like U937 cells
AJ Chu, J Moore, R Sime, WH Yu, Z Li |
Cell Biochemistry and Function | 1997 |
Protracted treatment with phorbol ester modulates j-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma
FN Ko, SM Yu, CM Teng |
International Journal of Cancer | 1994 |
Procoagulant activity of PPD-stimulated human lymphocytes after cryopreservation
G Hoheisel, M Roth, CH Chan, PW Ruff, DA Tsakiris, M Hornung, AP Perruchoud |
Tubercle and Lung Disease | 1994 |
A new blood-coagulating protease in mitochondrial membranes of rat submaxillary glands. Purification and characterization of protease and its blood-coagulating activity
D Bharadwaj, MS Roy, D Bose, RN Hati |
The Journal of biological chemistry | 1994 |
Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line
JR sheu, CH Lin, JL chung, CM Teng, TF Huang |
Thrombosis Research | 1992 |
Inhibition of endotoxin-induced monocytic procoagulant activity by n-alcohols and anesthetics
AJ Chu |
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology | 1991 |
Expression and Kinetics of Induced Procoagulant Activity in Bovine Pulmonary Alveolar Macrophages
BD Car, DO Slauson, MM Suyemoto, M Doré, NR Neilsen |
Experimental Lung Research | 1991 |
Urinary tissue factor activity in malignancy
N Carty, I Taylor, OS Roath, K El-Baruni, JL Francis |
Thrombosis Research | 1990 |
Procoagulant activity of mouse transformed cells: Different expression in freshly isolated or cultured cells
L Curatolo, MG Alessio, B Casali, A Falanga, MB Donati, N Semeraro |
In Vitro Cellular & Developmental Biology | 1989 |
Presence of Thrombosis-inducing Activity in Plasma from Patients with Lung Cancer
M Maruyama, K Yagawa, S Hayashi, M Kinjo, M Nakanishi, K Ogata, T Iwami, Y Ichinose, N Hara, M Ohta, N Shigematsu |
American journal of respiratory and critical care medicine | 1989 |
DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: Influence on lung colony formation
B Casali, MG Lampugnani, M Riganti, A Niewiarowska, G Alessio, L Mussoni, N Semeraro, MB Donati |
Clinical & Experimental Metastasis | 1988 |
Initiation of Coagulation by Tissue Facto
RR Bach |
Critical Reviews in Biochemistry and Molecular Biology | 1988 |
Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties
G Grignani, A Falanga, L Pacchiarini, MG Alessio, M Zucchella, P Fratino, MB Donati |
International Journal of Cancer | 1988 |
Monoclonal antibody analysis of purified and cell-associated tissue factor
JH Morrissey, DS Fair, TS Edgington |
Thrombosis Research | 1988 |
Effect of venom sac extract of the Oriental hornet (Vespa orientalis) on coagulation factors
A Kornberg, S Kaufman, L Silber, JS Ishay |
Toxicon | 1988 |
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics
A Falanga, AP Dalessandro, B Casali, MC Roncaglioni, MB Donati |
International Journal of Cancer | 1987 |
Tissue factor apoprotein: Intracellular transport and expression in shed membrane vesicles
R Bona, E Lee, F Rickles |
Thrombosis Research | 1987 |
Contribution of Tissue Factor Associated with Factor VII
S Idell, K Gonzalez, H Bradford, CK MacArthur, AM Fein, RJ Maunder, JG Garcia, DE Griffith, J Weiland, TR Martin, J McLarty, DS Fair, PN Walsh, RW Colman |
American journal of respiratory and critical care medicine | 1987 |
Bronchoalveolar Lavage Procoagulant Activity in Bleomycin-Induced Lung Injury in Marmosets: Characterization and Relationship to Fibrin Deposition and Fibrosis
S Idell, KK Gonzalez, CK MacArthur, C Gillies, PN Walsh, J McLarty, RS Thrall |
American journal of respiratory and critical care medicine | 1987 |
Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test
M Iitaka, J Bernstein, HC Gerstein, Y Iwatani, VV Row, R Volpé |
Journal of Endocrinological Investigation | 1986 |
In vitro generation of procoagulant activity by leukemic promyelocytes in reponse to cytotoxic drugs
E Fibach, A Treves, A Korenberg, EA Rachmilewitz |
American Journal of Hematology | 1985 |
Purification of glycosylated apoprotein of tissue factor from human brain and inhibition of its procoagulant activity by a specific antibody
H Tanaka, B Janssen, KT Preissner, G Müller-Berghaus |
Thrombosis Research | 1985 |
Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity
P G Cavanaugh, B F Sloane, A S Bajkowski, J D Taylor, K V Honn |
Thrombosis Research | 1985 |
Formation of the Fibrin Clot: the Balance of Procoagulant and Inhibitory Factors
B Lämmle, JH Griffin |
Clinics in Haematology | 1985 |
Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X
S Kurosawa, M Matsuda, N Aoki |
Thrombosis Research | 1984 |
Generation of Procoagulant Activity (PCA) by Macrophage-Like Cells Derived from Acute and Chronic Myeloid Leukaemia Cells in Response to Phorbol Esters
A Kornberg, A Treves, EA Rachmilewitz, E Fibach |
Scandinavian Journal of Haematology | 1983 |
TISSUE FACTOR: A VITAMIN K-DEPENDENT CLOTTING FACTOR?
LR Zacharski, R Rosenstein, PG Phillips |
Annals of the New York Academy of Sciences | 1981 |
In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins
H Prydz, T Lyberg, P Deteix, AC Allison |
Thrombosis Research | 1979 |
Purification and some properties of the protein component of tissue thromboplastin from human brain
E Bjorklid, E Storm |
Biochemical Journal | 1977 |
Struktur ? Funktion und analytischer Einsatz in biologischen Systemen
E Kttgen |
Klinische Wochenschrift | 1977 |
Interaction of concanavalin a with membrane-bound and solubilized lipoprotein lipase of rat heart
T Chajek, O Stein, Y Stein |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1976 |